| Product Code: ETC7382722 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Transarterial Chemoembolization (TACE) Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Transarterial Chemoembolization (TACE) Market - Industry Life Cycle |
3.4 Grenada Transarterial Chemoembolization (TACE) Market - Porter's Five Forces |
3.5 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Grenada Transarterial Chemoembolization (TACE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of liver cancer in Grenada |
4.2.2 Growing awareness about minimally invasive treatment options |
4.2.3 Advancements in technology leading to improved TACE procedures |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals |
4.3.2 High cost associated with TACE treatment |
4.3.3 Lack of reimbursement policies for TACE procedures in Grenada |
5 Grenada Transarterial Chemoembolization (TACE) Market Trends |
6 Grenada Transarterial Chemoembolization (TACE) Market, By Types |
6.1 Grenada Transarterial Chemoembolization (TACE) Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Conventional TACE, 2021- 2031F |
6.1.4 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By DEB-TACE, 2021- 2031F |
6.2 Grenada Transarterial Chemoembolization (TACE) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Unresectable HCC, 2021- 2031F |
6.2.3 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Early-Stage HCC, 2021- 2031F |
6.3 Grenada Transarterial Chemoembolization (TACE) Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Chemotherapeutic Agents, 2021- 2031F |
6.3.3 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Radiotherapeutic Agents, 2021- 2031F |
6.3.4 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Drug-eluting Particles, 2021- 2031F |
6.3.5 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Grenada Transarterial Chemoembolization (TACE) Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.4.5 Grenada Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Transarterial Chemoembolization (TACE) Market Import-Export Trade Statistics |
7.1 Grenada Transarterial Chemoembolization (TACE) Market Export to Major Countries |
7.2 Grenada Transarterial Chemoembolization (TACE) Market Imports from Major Countries |
8 Grenada Transarterial Chemoembolization (TACE) Market Key Performance Indicators |
8.1 Average waiting time for TACE treatment |
8.2 Number of TACE procedures performed annually |
8.3 Patient satisfaction rate with TACE treatment |
8.4 Rate of adoption of TACE procedures by healthcare facilities |
8.5 Number of research studies and clinical trials related to TACE in Grenada |
9 Grenada Transarterial Chemoembolization (TACE) Market - Opportunity Assessment |
9.1 Grenada Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Grenada Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Grenada Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 Grenada Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Grenada Transarterial Chemoembolization (TACE) Market - Competitive Landscape |
10.1 Grenada Transarterial Chemoembolization (TACE) Market Revenue Share, By Companies, 2024 |
10.2 Grenada Transarterial Chemoembolization (TACE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here